In this edition:
NSAID use & survival in ovarian cancer
Pre-/post-diagnosis MHT & survival in ovarian cancer
Suitability of Conquer Fear for ovarian cancer survivors
Novel targets in adenocarcinoma of the cervix & vulvar
A novel multi-omics immunopeptidomics platform for precision T-cell receptor therapy in ovarian cancer
Tumour-specific methylated DNA regions as early biomarkers for ovarian cancer
A ROR1 targeting antibody drug conjugate in high-grade serous ovarian cancer
Health-related QOL & symptom burden in endometrial cancer
Snapshot of treatments & outcomes in advanced stage ovarian carcinoma
Please login below to download this issue (PDF)